Therapeutic benefits targeting B-cells in chronic graft-versus-host disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic benefits targeting B-cells in chronic graft-versus-host disease
Authors
Keywords
Chronic graft-versus-host disease (cGVHD), B-cell immunity, Rituximab, Bortezomib, Tyrosine kinase inhibitors (TKIs)
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 101, Issue 5, Pages 438-451
Publisher
Springer Nature
Online
2015-03-27
DOI
10.1007/s12185-015-1782-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
- (2015) Sally Arai et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
- (2015) Joseph Pidala et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
- (2015) Christine E. Ryan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- B Cells in Chronic Graft-versus-Host Disease
- (2015) Stefanie Sarantopoulos et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
- (2015) Sally Arai et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- (2015) Madan H. Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Aberrant B-cell homeostasis in chronic GVHD
- (2015) S. Sarantopoulos et al. BLOOD
- Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans
- (2015) H. Nakasone et al. BLOOD
- Pancreatic atrophy in patients with chronic graft-versus-host disease
- (2014) Olga Rachel Brook et al. ABDOMINAL IMAGING
- Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria
- (2014) Zoya Kuzmina et al. AMERICAN JOURNAL OF HEMATOLOGY
- Second-Generation Tyrosine Kinase Inhibitors Combined With Stem Cell Transplantation in Patients With Imatinib-Refractory Chronic Myeloid Leukemia
- (2014) Yanmin Zhao et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease
- (2014) Alex F. Herrera et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treatment of chronic graft-versus-host disease with bortezomib
- (2014) C.-C. S. Pai et al. BLOOD
- Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans
- (2014) R. Flynn et al. BLOOD
- Increased BCR responsiveness in B cells from patients with chronic GVHD
- (2014) Jessica L. Allen et al. BLOOD
- Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD
- (2014) A. Khoder et al. BLOOD
- Current issues in chronic graft-versus-host disease
- (2014) G. Socie et al. BLOOD
- Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation
- (2014) H Nakasone et al. BONE MARROW TRANSPLANTATION
- Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2014) Avichai Shimoni et al. CANCER
- Clinical impact of H-Y alloimmunity
- (2014) Rakesh Popli et al. IMMUNOLOGIC RESEARCH
- Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
- (2014) Jason A. Dubovsky et al. JOURNAL OF CLINICAL INVESTIGATION
- CSF-1–dependant donor-derived macrophages mediate chronic graft-versus-host disease
- (2014) Kylie A. Alexander et al. JOURNAL OF CLINICAL INVESTIGATION
- Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease
- (2013) Bita Sahaf et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients
- (2013) Craig S. Sauter et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Plasma CXCL9 elevations correlate with chronic GVHD diagnosis
- (2013) C. L. Kitko et al. BLOOD
- Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD
- (2013) A. Olivieri et al. BLOOD
- Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling
- (2013) H. de Lavallade et al. BLOOD
- Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
- (2013) J. A. Dubovsky et al. BLOOD
- Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
- (2013) C. Cutler et al. BLOOD
- Incidence and risk factors for hypogammaglobulinemia in pediatric patients following allo-SCT
- (2013) H Frangoul et al. BONE MARROW TRANSPLANTATION
- Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation
- (2013) H Nakasone et al. BONE MARROW TRANSPLANTATION
- Risk factors and organ involvement of chronic GVHD in Japan
- (2013) J Kanda et al. BONE MARROW TRANSPLANTATION
- Thymic Damage, Impaired Negative Selection, and Development of Chronic Graft-versus-Host Disease Caused by Donor CD4+ and CD8+ T Cells
- (2013) T. Wu et al. JOURNAL OF IMMUNOLOGY
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease
- (2013) B. Sahaf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
- (2013) Hideki Nakasone et al. TRANSPLANT INTERNATIONAL
- Prophylactic and Preemptive Therapy with Dasatinib after Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- (2012) Giovanni Caocci et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Understanding Chronic GVHD from Different Angles
- (2012) Bruce Blazar et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD
- (2012) A. de Masson et al. BLOOD
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
- (2012) S. Arai et al. BLOOD
- B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways
- (2012) J. L. Allen et al. BLOOD
- Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation
- (2012) John Koreth et al. JOURNAL OF CLINICAL ONCOLOGY
- Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
- (2012) Ranjana H. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Donor B Cells in Transplants Augment Clonal Expansion and Survival of Pathogenic CD4+ T Cells That Mediate Autoimmune-like Chronic Graft-versus-Host Disease
- (2012) J. S. Young et al. JOURNAL OF IMMUNOLOGY
- Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-versus-Host Disease
- (2011) Isabel Sánchez-Ortega et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies
- (2011) G. L. Chen et al. BLOOD
- Association between serum high-molecular-weight adiponectin level and the severity of chronic graft-versus-host disease in allogeneic stem cell transplantation recipients
- (2011) H. Nakasone et al. BLOOD
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
- (2011) M. E. D. Flowers et al. BLOOD
- Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
- (2011) M. Srinivasan et al. BLOOD
- Treatment of chronic graft-versus-host disease in 2011
- (2011) Yoshihiro Inamoto et al. CURRENT OPINION IN HEMATOLOGY
- Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study
- (2011) J. Pidala et al. HAEMATOLOGICA
- Rituximab for prevention and treatment of graft-versus-host disease
- (2011) Mohamed A. Kharfan-Dabaja et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Alemtuzumab for the prevention and treatment of graft-versus-host disease
- (2011) Junya Kanda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Tirosin Kinase Inhibitors in Chronic Graft versus Host Disease: From Bench to Bedside
- (2011) Jacopo Olivieri et al. TheScientificWorldJOURNAL
- Rituximab in hematopoietic cell transplantation
- (2010) Sally Arai et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study
- (2010) S. J. Kim et al. HAEMATOLOGICA
- Hematopoietic Stem Cell TransplantationA Global Perspective
- (2010) Alois Gratwohl JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation
- (2010) Ken-ichi Matsuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Alloimmune Response Results in Expansion of Autoreactive Donor CD4+ T Cells in Transplants That Can Mediate Chronic Graft-versus-Host Disease
- (2010) D. Zhao et al. JOURNAL OF IMMUNOLOGY
- 50 years of allogeneic bone-marrow transplantation
- (2010) Ray Powles LANCET ONCOLOGY
- Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia
- (2010) H Nakasone et al. LEUKEMIA
- The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation
- (2010) S Thepot et al. LEUKEMIA
- The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant
- (2010) Amin M. Alousi et al. LEUKEMIA & LYMPHOMA
- Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation
- (2010) A. M. S. Muller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteasome Inhibition and Allogeneic Hematopoietic Stem Cell Transplantation: A Review
- (2009) John Koreth et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Rituximab Treatment before Reduced-Intensity Conditioning Transplantation Associates with a Decreased Incidence of Extensive Chronic GVHD
- (2009) Suzanne van Dorp et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis
- (2009) Mohamed A. Kharfan-Dabaja et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation—An Increasingly Recognized Manifestation of Chronic Graft-versus-Host Disease
- (2009) Jason W. Chien et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease
- (2009) L. Magro et al. BLOOD
- TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
- (2009) H. E. Kohrt et al. BLOOD
- Imatinib for refractory chronic graft-versus-host disease with fibrotic features
- (2009) A. Olivieri et al. BLOOD
- The role of B cells in the pathogenesis of graft-versus-host disease
- (2009) A. Shimabukuro-Vornhagen et al. BLOOD
- MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease
- (2009) W. Boukouaci et al. BLOOD
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
- (2009) S. Sarantopoulos et al. BLOOD
- Quality of life after allogeneic hematopoietic cell transplantation
- (2009) J. Pidala et al. BLOOD
- Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
- (2009) A. C. Vigorito et al. BLOOD
- Pancreatic atrophy is associated with gastrointestinal chronic GVHD following allogeneic PBSC transplantation
- (2009) H Nakasone et al. BONE MARROW TRANSPLANTATION
- Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation
- (2009) Voravit Ratanatharathorn et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical applications of rituximab in allogeneic stem cell transplantation: Anti-tumor and immunomodulatory effects
- (2009) Voravit Ratanatharathorn et al. CANCER TREATMENT REVIEWS
- Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
- (2009) Kirsten M. Williams JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Graft-versus-host disease
- (2009) James LM Ferrara et al. LANCET
- Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved Issues
- (2008) Yu-Waye Chu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
- (2008) I. F. Khouri et al. BLOOD
- Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor
- (2008) R. Santachiara et al. HAEMATOLOGICA
- Feasibility of NIH consensus criteria for chronic graft-versus-host disease
- (2008) B-S Cho et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation